TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: EMA 180 Day Review Questions Received

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    30/09/14
    08:49
    Post #: 14046684
    • Release Date: 30/09/14 08:29
    • Summary: EMA 180 Day Review Questions Received
    • Price Sensitive: No
    • Download Document    Not available as of the moment.
    Likes Created with Sketch.  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Thrilling study results take Orthocell a step closer to FDA clearance
right-arrow Created with Sketch.
NEWS OVD027 intercepts massive sulphide creating continued optimism
right-arrow Created with Sketch.
NEWS Peppermint looks to elevate AI and data transformation
right-arrow Created with Sketch.
RMS Flicka Lake Project enters promising new era as highly encouraging results found
right-arrow Created with Sketch.
NEWS Breaking news: HotCopper now open to capital raising!
right-arrow Created with Sketch.
USQ Expanded deep drilling gold program unveiled for Leonora flagship project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.